ロード中...
Carbapenem vs. Piperacillin-tazobactam for the Treatment of Ceftriaxone-Resistant Gram-Negative Bacteremia: Matched Cohorts by Propensity Score
BACKGROUND: Treatment of bacteremia caused by ESBL producing organisms remains controversial METHODS: Kaiser Permanente Northern California delivers care to 4 million members and is served by a centralized microbiological laboratory and an electronic medical record system. We identified patients hos...
保存先:
| 出版年: | Open Forum Infect Dis |
|---|---|
| 主要な著者: | , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Oxford University Press
2017
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5632089/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofx163.650 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|